# Progress Note 07 — Preventive Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Mahalia Jackson (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML035-SYN
- Date: 2026-10-05
- Fictional facility: St. Posthumous Health Center
- Fictional author: Beatrice Fontenot, MD
- Calendar frame: modern shifted

- Visit type: Preventive Visit
- Services: CPT 99396 (periodic preventive medicine, established patient, age 40 to 64) with CPT 99497 (advance care planning) on the same day

## Chief complaint

Periodic adult preventive visit. **S**

## History of present illness

Ms. Jackson, 52, comes for her yearly preventive visit six weeks after the review at which the repeat FDG-PET showed no active heart inflammation. Prednisone was reduced to 7.5 mg two weeks ago as planned; she takes methotrexate 20 mg weekly with folic acid, metoprolol, alendronate and vitamin D. She has more energy, climbs two flights of stairs without stopping, and has sung two concerts a week since the spring, with a longer tour planned for later in the autumn. The hoarseness in June settled within ten days. Her defibrillator has given no shocks, and the remote check last month was normal. She sleeps well now that the prednisone dose is lower. Her PHQ-9 today is 3. **S**

| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 52 |
| Active conditions | Pulmonary and cardiac sarcoidosis in remission on treatment; dual-chamber defibrillator; long-term glucocorticoids |
| Medicines | Prednisone 7.5 mg daily; methotrexate 20 mg weekly with folic acid 1 mg daily; metoprolol succinate 25 mg; alendronate 70 mg weekly; cholecalciferol 1000 units daily |
| Mood | PHQ-9 3 |

## Health risk assessment

Completed on paper in the waiting room and reviewed with her by Dr. Fontenot. **S**

| Domain | Finding |
|---|---|
| Self-rated health | Good, and much better than in the winter |
| Psychosocial | Faith and her church community are her strength; touring is tiring but is her purpose; worried about money while concerts were cancelled |
| Tobacco | Never smoked |
| Alcohol and drugs | No alcohol (she avoids it on methotrexate) and no drugs |
| Physical activity | Walks 30 minutes most days at home; less on tour |
| Nutrition | Home cooking at home; irregular meals on tour; has cut down on sweet drinks since her A1c rose; no calcium tablets, dairy twice a day |
| Sleep | Seven hours since the prednisone was lowered |
| Safety at home | Feels safe; no one hurts, threatens or controls her |
| Road safety | Wears a seat belt; driven on tour |
| Falls | No falls |
| Activities of daily living | Independent |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Energy better; no fever, night sweats or weight change |
| Eyes | Negative | No redness, pain, blurred vision or floaters |
| Ears, nose, mouth, and throat | Negative | Voice back to normal; no mouth sores |
| Cardiovascular | Negative | No chest pain, palpitations, fainting or device shocks |
| Respiratory | Negative | Breathless only on hills; no cough |
| Gastrointestinal | Negative | No heartburn with alendronate; no change in bowel habit or blood |
| Genitourinary | Negative | No urinary symptoms or vaginal bleeding |
| Breast | Negative | No lump, skin change or nipple discharge |
| Musculoskeletal | Negative | No bone pain or joint swelling |
| Integumentary | Negative | No rash, nodules or skin plaques; easy bruising less now |
| Neurological | Negative | No numbness, weakness or headache |
| Endocrine | Negative | No thirst or frequent urination |
| Psychiatric | Negative | Mood good; PHQ-9 3; no thoughts of self-harm |

13 systems reviewed. **S**

## Current medications

- Prednisone 5 mg oral tablet, one and a half tablets (7.5 mg) by mouth each morning **S**
- Methotrexate 2.5 mg oral tablet, eight tablets (20 mg) by mouth once a week on Sundays **S**
- Folic acid 1 mg oral tablet, one tablet by mouth daily **S**
- Alendronate 70 mg oral tablet, one tablet by mouth once weekly on rising, with a full glass of water, staying upright for 30 minutes **S**
- Metoprolol succinate 25 mg extended-release oral tablet, one tablet by mouth daily **S**
- Cholecalciferol (vitamin D3) 25 mcg (1000 units) oral tablet, one tablet by mouth daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 128/80 mmHg; pulse 66 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 92.2 kg; BMI 31.9 kg/m². All vital signs are synthetic.

Total cholesterol: 204 mg/dL (high); HDL cholesterol: 54 mg/dL; LDL cholesterol: 126 mg/dL; Triglycerides: 118 mg/dL; PHQ-9: 3. All results are synthetic.

## Immunizations given today

- Influenza vaccine, this season (inactivated) **S**
- COVID-19 mRNA vaccine, this season's formula **S**

## Physical examination

| System | Finding |
|---|---|
| Constitutional | Well; weight 92.2 kg, BMI 31.9; blood pressure 128/80 (average of two) |
| Eyes | No redness; pupils equal and reactive |
| Head, eyes, ears, nose, and throat | No thrush; voice clear |
| Neck | No lymph nodes; thyroid normal |
| Breasts | Examined with her agreement and a chaperone: no mass, skin change or nipple discharge; no axillary nodes |
| Cardiovascular | Regular rhythm; no murmur; defibrillator pocket healed; no ankle swelling |
| Respiratory | Clear to auscultation bilaterally |
| Abdomen | Old lower midline scar; soft; no liver or spleen enlargement |
| Pelvic | Speculum examination with her agreement and a chaperone: vaginal cuff healed, no cervix present |
| Skin | No rash, nodules or plaques; no suspicious lesions |
| Musculoskeletal | Height 170 cm, unchanged; no spinal tenderness |
| Psychiatric | Warm, lively, engaged |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Periodic adult preventive visit completed**. Health risk assessment reviewed and the prevention plan updated for a woman of 52 on long-term glucocorticoids and methotrexate. Total cholesterol 204, HDL 54, LDL 126 mg/dL, triglycerides 118; her ten-year cardiovascular risk is about 4 percent, so a statin is not recommended now, with lifestyle advice and a recheck in a year. A1c 6.2% in August is in the prediabetes range, partly from prednisone; a diabetes prevention program was offered. Mammography is due. Colonoscopy six years ago was normal. Cervical screening is not needed: the examination today shows no cervix after her hysterectomy, and she has no history of cervical precancer. Influenza and COVID-19 vaccines given today; her pneumococcal, zoster and hepatitis B series are complete; no live vaccines on her current treatment. **S**
   - Influenza and COVID-19 vaccines given today.
   - Screening mammogram ordered.
   - Diabetes prevention program referral.
   - Lipids and A1c again in one year, or sooner if prednisone is increased.
   - Next preventive visit in one year.
2. **Cardiac sarcoidosis in remission on treatment, with a defibrillator** (D86.85). No palpitations or shocks; regular rhythm; remote device check last month normal. **S**
   - Continue the prednisone taper as planned by Dr. Asante-Miller and cardiology.
   - Continue methotrexate 20 mg weekly.
   - Methotrexate safety blood tests next month.
3. **Long-term systemic glucocorticoids** (Z79.52). Bone density in March showed a femoral neck T-score of -1.6 on starting prednisone; on alendronate, with dietary calcium and vitamin D 1000 units, and calcium normal. **S**
   - Continue alendronate while on prednisone.
   - Repeat bone density scan two years after the first.
   - Eye examination with pressure check in March, one year after the first.

## Personalized prevention plan

A written copy was given to the patient. **S**

| Service | Status | Detail |
|---|---|---|
| Blood pressure screening | Completed today | 128/80 mmHg, lower than on high-dose prednisone |
| Depression screening | Completed today | PHQ-9 score 3; item 9 scored 0 |
| Unhealthy alcohol use screening | Completed today | No alcohol |
| Tobacco use | Completed today | Never smoked |
| Intimate partner violence screening | Completed today | Negative; she feels safe |
| Breast cancer screening | Ordered | Mammogram every two years from 40; last one three years ago; ordered today |
| Colorectal cancer screening | Up to date | Colonoscopy six years ago normal; next due in four years |
| Cervical cancer screening | Not indicated | No cervix on examination today after hysterectomy, and no history of cervical precancer |
| Diabetes screening | Completed today | A1c 6.2% in August: prediabetes; diabetes prevention program offered |
| Cholesterol screening and statin decision | Completed today | Total cholesterol 204, HDL 54, LDL 126 mg/dL; ten-year risk about 4 percent; no statin now |
| Osteoporosis screening and glucocorticoid bone protection | Up to date | Bone density in March, T-score -1.6; on alendronate; repeat in two years |
| HIV and hepatitis C screening | Up to date | Both negative at the consultation in February |
| Influenza vaccine | Completed today | Inactivated vaccine given |
| COVID-19 vaccine | Completed today | This season's mRNA vaccine given |
| Pneumococcal vaccine | Up to date | PCV20 in March, before immunosuppression |
| Recombinant zoster vaccine | Up to date | Two doses, March and August |
| Hepatitis B vaccine | Up to date | Two-dose adjuvanted series completed in May |
| Tetanus, diphtheria, and pertussis | Up to date | Tdap six years ago |
| Live vaccines (MMR, varicella) | Not indicated | Avoided on prednisone and methotrexate |
| Eye examination | Up to date | Ophthalmology in March normal (no uveitis); yearly while on glucocorticoids and with sarcoidosis |
| Dental examination | Due | Before the autumn tour; alendronate noted for the dentist |

## Advance care planning

Voluntary advance care planning discussion of about 30 minutes, with her consent. She named a health care agent, recorded in the confidential part of the chart and not named here, and completed a health care power of attorney. She said that her faith guides her, that she wants every treatment that gives her a good chance to live and to sing, and that if she became so ill that she could not recover to know and pray with the people around her, she would want comfort care and her church's prayers rather than machines. The defibrillator was explained: it can be switched off painlessly by the device team if she ever chooses comfort care at the end of life, and she asked that this be discussed with her agent then. To be revisited at each change in her health and at least yearly. **S**

## Guideline basis

- Birnie DH, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 2014;11(7):1305-1323 (PMID 24819193) (2014), Heart Rhythm Society
- Humphrey MB, et al. 2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. Arthritis Rheumatol 2023;75(12):2088-2102 (PMID 37845798) (2022), American College of Rheumatology
- Adult Immunization Schedule by Medical Condition and Other Indication (2026), Centers for Disease Control and Prevention
- Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026), Aether Forge
- USPSTF A and B Recommendations (2026), U.S. Preventive Services Task Force
- Breast Cancer: Screening (2024), U.S. Preventive Services Task Force
- Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication (2022), U.S. Preventive Services Task Force

## Follow-up

- Mammogram within the month. Methotrexate blood tests next month. Pulmonology and cardiology as planned. Next preventive visit in one year. **S**

